Navigation Links
Intravenous Access Devices Market is Expected to Reach USD 46.5 Billion Globally in 2019: Transparency Market Research
Date:12/9/2013

ALBANY, New York, December 9, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research "Intravenous Access Devices Market (Intravenous Needles, Intravenous Catheters and Intravenous Infusion Pumps) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,"in 2012, the global intravenous access devices market was valued at USD 27.2 billion and is expected to grow at a CAGR of 7.8% during the forecast period of 2013 to 2019  to reach a market value of USD 46.5 billion by 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/intravenous-access-devices.html

Intravenous (IV) access devices are utilized extensively for the delivery of almost every class of drugs such as analgesics, antibiotics and antipyretics. The IV access devices include IV needles, IV catheters and IV infusion pumps. The market for IV access devices will increase tremendously at the growing rate of 7.8% during the forecast period 2013 to 2019 with the increasing incidences of various diseases such as cancer and tuberculosis (TB).Increasing geriatric population worldwide will also support the growth of this market because elderly people are highly susceptible to aforementioned diseases. In addition, shifting trend towards home healthcare will further propel the growth of infusion pumps and catheters market which will also support the overall growth of the market.

Likewise, increase in number of surgeries throughout the globe will also trigger the growth of this market since; surgeries will require these access devices for various purposes such as medication and anesthetic. For instance, in 2012around 51.4 surgeries were reported according to the Centers for Disease Control and Prevention (CDC) in the U.S. and this number is expected to increase owing to various reasons such as increase in number of accidents and lifestyle.Similarly, increase in number of vaccines will also augment the growth of this market since administration of majority of the vaccines will utilize intravenous needles.The market for intravenous catheters is expected to grow at the highest CAGR of 9% during the forecast period 2013 to 2019. This growth is attributed to its wide application areas such as it is utilized when infusion pump is implanted in the body. Similarly, price competitiveness of the catheters will also support the growth of this market tremendously.

The North American region accounted for the largest share by revenue for intravenous access devices in the year 2012 owing to large number of patient pool and geriatric population. However, Asia-Pacific is expected to show the highest growth rate of 9.4% from 2013 to 2019. This is attributed to rise in geriatric population, target diseases, increase in healthcare expenditure and improving healthcare infrastructure in the Asia-Pacific region. In addition, rise in disposable income due to economic development will also propel the growth of the market in the region since it will increase the purchasing power of individuals for various medical services such as surgeries.

Related & Recently Published Reports by Transparency Market Research

The major players operating in the market include Hospira, Inc., Becton, Dickinson and Company, CareFusion Corporation, Baxter International, B. Braun Melsungen AG and Smiths Medical.

The global intravenous access devicesmarket has been segmented as below:

Intravenous Access Devices Market, by Product Types

  • Intravenous Needles
  • Intravenous Catheters
    • Midline Peripheral Catheter
    • Central Catheters
      • Midline Peripheral Catheters
      • Centrally Inserted Catheters
  • Intravenous Infusion Pumps
    • Intravenous Insulin infusion Pumps
    • Parenteral Feeding Infusion Pumps
    • Intravenous Patient Controlled Analgesia (PCA) Infusion Pumps
    • Intravenous Syringe Infusion Pumps

Intravenous Access Devices Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: +1-866-552-3453

Email: sales@transparencymarketresearch.com

Web: http://www.transparencymarketresearch.com/

Blog: http://www.tmrblog.com/

Blog: http://tmralbany.wordpress.com/



'/>"/>
SOURCE http://www.transparencymarketresearch.com/
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Intravenous Equipment - Global Strategic Business Report
2. 2013 China Human Immunoglobulin (pH4) for Intravenous Injection Industry Research Report
3. Systematic Review Finds Intranasal Midazolam Comparable To Intravenous Or Rectal Administration Of Diazepam For Treatment Of Acute Seizure Emergencies In Pediatric Patients
4. B. Braun Receives FDA Approval For New Large-Volume Intravenous Containers
5. Global Intravenous Solutions (Parenteral Nutrition) Industry
6. Phase 3 Data Show Intravenous Golimumab Inhibited Radiographic Progression in Patients with Active Rheumatoid Arthritis
7. Johnson & Johnson Announces Discontinuation of Phase 3 Development of Bapineuzumab Intravenous (IV) in Mild-to-Moderate Alzheimers Disease
8. Jennerex Announces First Patient Treated in Phase 2 Clinical Trial of Intravenous Delivery JX-594 In Patients with Advanced Liver Cancer
9. Physician-Patient Alliance for Health & Safety Announces New Expert Checklist for Facilitating Safety of Hospital-Based Intravenous Patient-Controlled Analgesia Pumps
10. Catheters (Cardiovascular, Specialty, Urological, Neurovascular, and Intravenous) Market Will Reach USD 33.3 Billion Globally in 2017: Transparency Market Research
11. Roundtable of Biopharma Industry Leaders Offers Insights to Market Access Challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Health and Gateway Health proudly announce a dynamic collaboration that ... plan members with specific high risk needs. In ... group of consumers, Wellbridge combines technology and population expertise with ... members, daily behaviors and lifestyle. ... , , ...
(Date:12/5/2016)...  New research by the CVS Health (NYSE: ... U.S. Department of Health and Human Services, Office ... (ASPR), published online today in JAMA Internal ... patients with chronic conditions to refill medications prior ... affirms that public-private partnerships can facilitate timely pharmacy ...
(Date:12/5/2016)... 5, 2016  BD (Becton, Dickinson and Company) (NYSE: ... company, will demonstrate an enhanced technology platform designed with ... the company,s leading Pyxis™ and Alaris™ systems, at this ... Midyear Meeting being held in Las ... national data show that approximately 68 percent of medication ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... 03, 2016 , ... Penrose Senior Care Auditors® was announced ... evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony and Banquet ... for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ingenuity, commitment ...
(Date:12/4/2016)... , ... December 04, 2016 , ... ... major cosmetic surgery can now take advantage of a cosmetic procedure known as ... rejuvenation treatment that reduces the appearance of age spots, fine lines, uneven ...
(Date:12/4/2016)... PITTSBURGH, PA (PRWEB) , ... December 04, 2016 , ... ... not enough. One must brush properly to achieve optimal results. This important necessity inspired ... saw a need for a way to ensure that people break or avoid bad ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in ... Conference Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New ... Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and ...
(Date:12/2/2016)... DIEGO, Calif. (PRWEB) , ... December 02, 2016 , ... ... Event at the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals ... myeloproliferative neoplasms (MPNs) by going above and beyond the standard of care, demonstrating leadership ...
Breaking Medicine News(10 mins):